ASC30 for Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This is a phase I, randomized, double-blind, placebo-controlled, single and multiple ascending dose study to evaluate the safety, tolerability, pharmacokinetics, efficacy, food effect of ASC30 Tablets or ASC30 Tablets A1 in participants with obesity.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, since the trial excludes participants with certain health conditions, it's possible that some medications might not be allowed. Please consult with the trial coordinator for more details.
What safety data exists for ASC30 treatment for obesity?
Is the drug ASC30 a promising treatment for obesity?
What data supports the idea that ASC30 for Obesity is an effective treatment?
The available research does not provide specific data on ASC30 for Obesity, so we cannot determine its effectiveness from the information given. The studies focus on other aspects of obesity treatment, such as the importance of long-term support and the challenges in recognizing and documenting obesity. Without direct data on ASC30, we can't compare it to other treatments or confirm its effectiveness.1112131415
Are You a Good Fit for This Trial?
This trial is for individuals with obesity who are interested in testing a new treatment. Participants must meet certain health criteria to join, but specific inclusion and exclusion details aren't provided here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Single Ascending Dose (SAD) Treatment
Participants receive single ascending doses of ASC30 to evaluate safety, tolerability, and pharmacokinetics
Multiple Ascending Dose (MAD) Treatment
Participants receive multiple ascending doses of ASC30 to evaluate safety, tolerability, and pharmacokinetics
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ASC30
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ascletis Pharma (China) Co., Limited
Lead Sponsor